Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Primary Glioblastoma × 1 year × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 2152 Neoplasms 1652 Carcinoma, Non-Small-Cell Lung 1428 Prostatic Neoplasms 1200 Colorectal Neoplasms 981 Lung Neoplasms 875 Neoplasm Metastasis 738 Multiple Myeloma 718 Leukemia, Myeloid, Acute 697 Ovarian Neoplasms 609 Pancreatic Neoplasms 604 Melanoma 600 Squamous Cell Carcinoma of Head and Neck 525 Recurrence 513 Carcinoma, Hepatocellular 501 Brain Neoplasms 477 Glioblastoma 457 Stomach Neoplasms 450 Head and Neck Neoplasms 427 Lymphoma 417 Triple Negative Breast Neoplasms 412 Uterine Cervical Neoplasms 394 Precursor Cell Lymphoblastic Leukemia-Lymphoma 388 Carcinoma, Renal Cell 373 Lymphoma, Non-Hodgkin 359 Endometrial Neoplasms 347 Sarcoma 325 Urinary Bladder Neoplasms 324 Lymphoma, Large B-Cell, Diffuse 313 Colonic Neoplasms 313

Interventions

pembrolizumab 1 Temozolomide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07347210 2026-01-16

MATVAC-1

Centre Hospitalier Universitaire de Besancon

Phase 2 Not yet recruiting

Primary Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡